Investment Director
Joined: 2017
and access,
Renée joined Duke Street in 2017 from Charles River Associates in Munich, where she was a strategic and operational management consultant for the healthcare industry as well as Private Equity clients. At Duke Street, her regional focus spans across western Europe, with particular concentration on DACH markets, and her sector expertise and origination focus is in healthcare. She has worked on the firm’s investments in A-ROSA and Kent Pharmaceuticals and sits on the boards of Medi-Globe, A-ROSA and Kent. Renée holds a BA (Hons) in Biology from New York University and an MSc in Neuroscience from Ludwig-Maximilians University in Munich.
